Search
Tony Keating says the company is excited about the preliminary results. Photo: Attila Csaszar

ResApp shares down on study results

Shares in medical tech company ResApp Health slumped today after it released positive test results, following a spike in the share price leading up to the announcement.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
14thDimerix852%88%
465thJV Global0%-11%
750thResApp Health-54%132%
768thIntiger Group-62%14%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

05/10/17
$65k Bought
16/12/16
$49k Bought
16/12/16
$49k Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

144th↑ResApp Health$1.1m
159th↓xTV Networks$561k
160th↓Dimerix$536k
162nd↑Intiger Group$489k
163rd↓JV Global$487k
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from ResApp Health

192ndTony Keating$537k
1018thBrian Leedman$78k
330thRoger Aston$72k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer